Inhibition of in vitro donor-specific proliferative and cytotoxic T cell responses in chimeric CD40 ligand-deficient bone marrow transplant recipients treated perioperatively with CTLA4-Ig.
Department of Surgery, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA.
J E
JE
Woodward
A T
AT
Schaefer
L B
LB
Zottola
J K
JK
Stazer
A J
AJ
Logar
R
R
Peach
A S
AS
Rao
D000069594:Abatacept; D000818:Animals; D015703:Antigens, CD; D000943:Antigens, Differentiation / Q000494:pharmacology; D016026:Bone Marrow Transplantation / Q000276:immunology*; D023201:CD40 Ligand / Q000276:immunology; D060908:CTLA-4 Antigen; D002455:Cell Division; D007111:Immunity, Cellular; D018796:Immunoconjugates; D007166:Immunosuppressive Agents / Q000494:pharmacology; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D008808:Mice, Inbred CBA; D011828:Radiation Chimera / Q000276:immunology; D013602:T-Lymphocytes, Cytotoxic / Q000187:drug effects / Q000276:immunology*; D018183:Transplantation Chimera / Q000276:immunology*; D023001:Transplantation Tolerance / Q000187:drug effects / Q000276:immunology*
D015703:Antigens, CD; D000943:Antigens, Differentiation; D060908:CTLA-4 Antigen; C556707:Ctla4 protein, mouse; D018796:Immunoconjugates; D007166:Immunosuppressive Agents; D023201:CD40 Ligand; D000069594:Abatacept